Skip to main content
Erschienen in: Journal of Clinical Immunology 8/2015

Open Access 01.11.2015 | Original Research

The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies

verfasst von: Aziz Bousfiha, Leïla Jeddane, Waleed Al-Herz, Fatima Ailal, Jean‐Laurent Casanova, Talal Chatila, Mary Ellen Conley, Charlotte Cunningham‐Rundles, Amos Etzioni, Jose Luis Franco, H. Bobby Gaspar, Steven M. Holland, Christoph Klein, Shigeaki Nonoyama, Hans D. Ochs, Eric Oksenhendler, Capucine Picard, Jennifer M. Puck, Kathleen E. Sullivan, Mimi L. K. Tang

Erschienen in: Journal of Clinical Immunology | Ausgabe 8/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

There are now nearly 300 single-gene inborn errors of immunity underlying phenotypes as diverse as infection, malignancy, allergy, auto-immunity, and auto-inflammation. For each of these five categories, a growing variety of phenotypes are ascribed to Primary Immunodeficiency Diseases (PID), making PIDs a rapidly expanding field of medicine. The International Union of Immunological Societies (IUIS) PID expert committee (EC) has published every other year a classification of these disorders into tables, defined by shared pathogenesis and/or clinical consequences. In 2013, the IUIS committee also proposed a more user-friendly, phenotypic classification, based on the selection of key phenotypes at the bedside. We herein propose the revised figures, based on the accompanying 2015 IUIS PID EC classification.
Abkürzungen
αFP
Alpha- fetoprotein
Ab
Antibody
AD
Autosomal dominant inheritance
ADA
Adenosine deaminase
Adp
Adenopathy
ALPS
Autoimmune lymphoproliferative syndrome
AML
Acute myeloid leukemia
Anti PPS
Anti- pneumococcus antibody
AR
Autosomal recessive inheritance
BCG
Bacilli Calmette-Guerin
BL
B lymphocyte
CAMPS
CARD14 mediated psoriasis
CANDLE
Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome
CAPS
Cryopyrin-associated periodic syndromes
CBC
Complete blood count
CD
Cluster of differentiation
CDG-IIb
Congenital disorder of glycosylation, type IIb
CGD
Chronic granulomatous disease
CID
Combined immunodeficiency
CINCA
Chronic infantile neurologic cutaneous and articular syndrome
CMC
Chronic mucocutaneous candidiasis
CMF
Flow cytometry available
CMV
Cytomegalovirus
CMML
Chronic myelomonocytic leukemia
CNS
Central nervous system
CSF
Cerebrospinal fluid
CT
Computed tomography
CTL
Cytotoxic T-lymphocyte
DA
Duration of attacks
Def
Deficiency
DHR
DiHydroRhodamine
Dip
Diphtheria
DITRA
Deficiency of interleukin 36 receptor antagonist
EBV
Epstein-Barr virus
EDA
Anhidrotic ectodermal dysplasia
EDA-ID
Anhidrotic ectodermal dysplasia with immunodeficiency
EO
Eosinophils
FA
Frequency of attacks
FCAS
Familial cold autoinflammatory syndrome
FILS
Facial dysmorphism, immunodeficiency, livedo, and short stature
FISH
Fluorescence in situ hybridization
GI
Gastrointestinal
GOF
Gain-of-function
HHV8
Human herpes virus type 8
Hib
Haemophilus influenzae serotype b
HIDS
Hyper IgD syndrome
HIES
Hyper IgE syndrome
HIGM
Hyper Ig M syndrome
HLA
Human leukocyte antigen
HLH
Hemophagocytic lymphohistiocytosis
HPV
Human papilloma virus
HSM
Hepatosplenomegaly
HSV
Herpes simplex virus
HUS
Hemolytic uremic syndrome
Hx
Medical history
IBD
Inflammatory bowel disease
IFNγ
Interferon gamma
Ig
Immunoglobulin
IL
Interleukin
IUGR
Intrauterine growth retard
LAD
Leukocyte adhesion deficiency
LOF
Loss-of-function
MC
Molluscum contagiosum
MKD
Mevalonate kinase deficiency
MSMD
Mendelian susceptibility to mycobacterial disease
MWS
Muckle-wells syndrome
N
Normal, not low
NK
Natural killer
NKT
Natural killer T cell
NN
Neonatal
NOMID
Neonatal onset multisystem inflammatory disease
NP
Neutropenia
PAPA
Pyogenic sterile arthritis, pyoderma gangrenosum, acne syndrome
PMN
Neutrophils
SCID
Severe combined immuno deficiency
Sd
Syndrome
SLE
Systemic lupus erythematosus
SPM
Splenomegaly
Staph
Staphylococcus sp.
subcl
Subclass
TCR
T-cell receptor
Tet
Tetanus
T
T lymphocyte
TNF
Tumor necrosis factor
TRAPS
TNF receptor-associated periodic syndrome
VZV
Varicella zoster virus
WBC
White blood cells
XL
X-linked

Introduction

Human Primary Immunodeficiency Diseases (PID) comprise at least 300 genetically-defined single-gene inborn errors of immunity [1]. Long considered as rare diseases, recent studies tend to show that they are more common than generally thought, if only by their rapidly increasing number [2]. They may be even more common, if we consider the emerging monogenic determinants leading to common infectious diseases, such as severe influenza [3]; autoimmune diseases, such as systemic lupus erythematosus [4], and auto-inflammatory diseases, such as Crohn’s disease [5]. The International Union of Immunological Societies (IUIS) PID expert committee has proposed a PID classification [1], which facilitates clinical research and comparative studies world-wide; it is updated every other year to include new disorders or disease-causing genes. This classification is organized in tables, each of which groups PIDs that share a given pathogenesis. As this classification may be cumbersome for use by the clinician at the bedside, the IUIS PID expert committee recently proposed a phenotypic complement to its classification [6]. As the number of PIDs is quickly increasing, and at an even faster pace since the advent of next-generation sequencing, the phenotypic classification from 2013 became outdated and requires revision at the same pace as the classical IUIS classification. Our original phenotypic classification proved successful, which placed it in the 96th percentile for citation rank in Springer journals [7]. Given the success of our user-friendly classification of PIDs, providing a tree-based decision-making process based on the observation of clinical and biological phenotypes, we present here an update of these figures, based on the accompanying 2015 PID classification.

Methodology

We included all diseases included in the 2015 update of the IUIS PID classification [1], keeping the nine major categories unchanged. In addition, we considered other articles proposing a PID classification published recently [8, 9]. An algorithm was assigned to each of the nine main groups of the classification and the same color was used for each group of similar conditions. Disease names are presented in red and genes in bold. In addition, we classed diseases or genes from most common to less common, at the best of our knowledge [10, 11]. These algorithms were first established by a small committee; then validated by one or two experts for each figure.

Results

An update of our classification, validated by the IUIS PID expert committee, is presented in Figs. 1, 2, 3, 4, 5, 6, 7, 8 and 9.

Discussion

Since our 2013 study, 70 new diseases have been included in the 2015 classification. Four disorders have been removed, as the reports concerning associated immunodeficiency or genetic base were not confirmed. We also eliminated duplication of a disease in more than one figure and profoundly revised some figures, following the 2015 IUIS classification.

Conclusion

The IUIS PID expert committee developed this phenotypic classification in order to help clinicians at the bedside to diagnose PIDs but also to promote collaboration with national and international research centers. Needless to say, the expert committee encourages the development of other types of PID classification. Indeed, given the success encountered by the two current IUIS classifications, others classifications are likely to be useful and complementary.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat IUIS classification (to be precised) 2015. IUIS classification (to be precised) 2015.
2.
Zurück zum Zitat Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7.CrossRefPubMed Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7.CrossRefPubMed
3.
Zurück zum Zitat Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, et al. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 2015;348(6233):448–53.CrossRefPubMed Ciancanelli MJ, Huang SX, Luthra P, Garner H, Itan Y, Volpi S, et al. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 2015;348(6233):448–53.CrossRefPubMed
4.
Zurück zum Zitat Troedson C, Wong M, Dalby-Payne J, Wilson M, Dexter M, Rice GI, et al. Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy. Lupus. 2013;22(6):639–43.CrossRefPubMed Troedson C, Wong M, Dalby-Payne J, Wilson M, Dexter M, Rice GI, et al. Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy. Lupus. 2013;22(6):639–43.CrossRefPubMed
5.
Zurück zum Zitat Sewell GW, Rahman FZ, Levine AP, Jostins L, Smith PJ, Walker AP, et al. Defective tumor necrosis factor release from Crohn’s disease macrophages in response to Toll-like receptor activation: relationship to phenotype and genome-wide association susceptibility loci. Inflamm Bowel Dis. 2012;18(11):2120–7.PubMedCentralCrossRefPubMed Sewell GW, Rahman FZ, Levine AP, Jostins L, Smith PJ, Walker AP, et al. Defective tumor necrosis factor release from Crohn’s disease macrophages in response to Toll-like receptor activation: relationship to phenotype and genome-wide association susceptibility loci. Inflamm Bowel Dis. 2012;18(11):2120–7.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87.PubMedCentralCrossRefPubMed Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078–87.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Springer Science. In: Citations Springer. 2015. http://citations.springer.com/item?doi=10.1007/s10875-013-9901-6. Accessed 20 Jul 2015. Springer Science. In: Citations Springer. 2015. http://​citations.​springer.​com/​item?​doi=​10.​1007/​s10875-013-9901-6. Accessed 20 Jul 2015.
8.
Zurück zum Zitat Ochs HD, Hagin D. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. Ann Allergy Asthma Immunol. 2014;112(6):489–95.CrossRefPubMed Ochs HD, Hagin D. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. Ann Allergy Asthma Immunol. 2014;112(6):489–95.CrossRefPubMed
9.
Zurück zum Zitat Federici S, Martini A, Gattorno M. The central role of anti-IL1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013;4:351.PubMedCentralCrossRefPubMed Federici S, Martini A, Gattorno M. The central role of anti-IL1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013;4:351.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132–44.CrossRefPubMed Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132–44.CrossRefPubMed
11.
Zurück zum Zitat Online Mendelian Inheritance in Man (OMIM). An Online Catalog of Human Genes and Genetic Disorders. In: Online Mendelian Inheritance in Man. http://omim.org/ Accessed 20 Jul 2015. Online Mendelian Inheritance in Man (OMIM). An Online Catalog of Human Genes and Genetic Disorders. In: Online Mendelian Inheritance in Man. http://​omim.​org/​ Accessed 20 Jul 2015.
Metadaten
Titel
The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies
verfasst von
Aziz Bousfiha
Leïla Jeddane
Waleed Al-Herz
Fatima Ailal
Jean‐Laurent Casanova
Talal Chatila
Mary Ellen Conley
Charlotte Cunningham‐Rundles
Amos Etzioni
Jose Luis Franco
H. Bobby Gaspar
Steven M. Holland
Christoph Klein
Shigeaki Nonoyama
Hans D. Ochs
Eric Oksenhendler
Capucine Picard
Jennifer M. Puck
Kathleen E. Sullivan
Mimi L. K. Tang
Publikationsdatum
01.11.2015
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 8/2015
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-015-0198-5

Weitere Artikel der Ausgabe 8/2015

Journal of Clinical Immunology 8/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.